Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price was up 2.6% on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.15 ($0.04). Approximately 555,891 shares traded hands during trading, an increase of 247% from the average daily volume of 160,411 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Performance
The company has a 50-day moving average of GBX 2.71 and a 200-day moving average of GBX 3.16. The firm has a market capitalization of £9.31 million, a price-to-earnings ratio of -315.30 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- The Significance of Brokerage Rankings in Stock Selection
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- How to Start Investing in Real Estate
- CarMax Gets in Gear: Is Now the Time to Buy?
- Most Volatile Stocks, What Investors Need to Know
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
